{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T05:20:11Z","timestamp":1731561611723,"version":"3.28.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,11,13]]},"DOI":"10.7759\/cureus.73582","type":"journal-article","created":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T11:23:56Z","timestamp":1731497036000},"source":"Crossref","is-referenced-by-count":0,"title":["Atomoxetine-Induced Pheochromocytoma and Paraganglioma Crisis Managed With Veno-Arterial Extracorporeal Membrane Oxygenation"],"prefix":"10.7759","author":[{"given":"Hirotsugu","family":"Kaneshima","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoya","family":"Miura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asuka","family":"Tsuchiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiji","family":"Morita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihide","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.6010","article-title":"Management of pheochromocytomas and paragangliomas: review of current diagnosis and treatment options","volume":"12","author":"Eid M","year":"2023","unstructured":"Eid M, Foukal J, Sochorov\u00e1 D, et al.. Management of pheochromocytomas and paragangliomas: review of current diagnosis and treatment options. Cancer Med. 2023, 12:13942-57. 10.1002\/cam4.6010","journal-title":"Cancer Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1806651","article-title":"Pheochromocytoma and paraganglioma","volume":"381","author":"Neumann HP","year":"2019","unstructured":"Neumann HP, Young WF Jr, Eng C. Pheochromocytoma and paraganglioma. N Engl J Med. 2019, 381:552-65. 10.1056\/NEJMra1806651","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajem.2018.03.009","article-title":"Metoclopramide induced pheochromocytoma crisis","volume":"36","author":"Leonard JB","year":"2018","unstructured":"Leonard JB, Munir KM, Kim HK. Metoclopramide induced pheochromocytoma crisis. Am J Emerg Med. 2018, 36:1124.e1-2. 10.1016\/j.ajem.2018.03.009","journal-title":"Am J Emerg Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9082435","article-title":"Cardiovascular manifestations and complications of pheochromocytomas and paragangliomas","volume":"9","author":"Y-Hassan S","year":"2020","unstructured":"Y-Hassan S, Falhammar H. Cardiovascular manifestations and complications of pheochromocytomas and paragangliomas. J Clin Med. 2020, 9:2435. 10.3390\/jcm9082435","journal-title":"J Clin Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.5173\/ceju.2014.02.art7","article-title":"Adrenergic crisis due to pheochromocytoma - practical aspects. A short review","volume":"67","author":"Juszczak K","year":"2014","unstructured":"Juszczak K, Drewa T. Adrenergic crisis due to pheochromocytoma - practical aspects. A short review. Cent European J Urol. 2014, 67:153-5. 10.5173\/ceju.2014.02.art7","journal-title":"Cent European J Urol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-022-01868-6","article-title":"Clinical characteristics and outcomes of pheochromocytoma crisis: a literature review of 200 cases","volume":"45","author":"Ando Y","year":"2022","unstructured":"Ando Y, Ono Y, Sano A, Fujita N, Ono S, Tanaka Y. Clinical characteristics and outcomes of pheochromocytoma crisis: a literature review of 200 cases. J Endocrinol Invest. 2022, 45:2313-28. 10.1007\/s40618-022-01868-6","journal-title":"J Endocrinol Invest"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.4102\/sajpsychiatry.v29i0.2152","article-title":"A review of recent treatments for adults living with attention-deficit\/hyperactivity disorder","volume":"29","author":"Wakelin C","year":"2023","unstructured":"Wakelin C, Willemse M, Munnik E. A review of recent treatments for adults living with attention-deficit\/hyperactivity disorder. S Afr J Psychiatr. 2023, 29:2152. 10.4102\/sajpsychiatry.v29i0.2152","journal-title":"S Afr J Psychiatr"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s12094-021-02622-9","article-title":"Multidisciplinary practice guidelines for the diagnosis, genetic counseling and treatment of pheochromocytomas and paragangliomas","volume":"23","author":"Garcia-Carbonero R","year":"2021","unstructured":"Garcia-Carbonero R, Matute Teresa F, Mercader-Cidoncha E, et al.. Multidisciplinary practice guidelines for the diagnosis, genetic counseling and treatment of pheochromocytomas and paragangliomas. Clin Transl Oncol. 2021, 23:1995-2019. 10.1007\/s12094-021-02622-9","journal-title":"Clin Transl Oncol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000002198","article-title":"Acute and chronic pheochromocytoma-induced cardiomyopathies: different prognoses?: a systematic analytical review","volume":"94","author":"Batisse-Lignier M","year":"2015","unstructured":"Batisse-Lignier M, Pereira B, Motreff P, et al.. Acute and chronic pheochromocytoma-induced cardiomyopathies: different prognoses?: a systematic analytical review. Medicine (Baltimore). 2015, 94:e2198. 10.1097\/MD.0000000000002198","journal-title":"Medicine (Baltimore)"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2023.05.004","article-title":"Pheochromocytoma-induced cardiogenic shock: a multicentre analysis of clinical profiles, management and outcomes","volume":"383","author":"De Angelis E","year":"2023","unstructured":"De Angelis E, Bochaton T, Ammirati E, et al.. Pheochromocytoma-induced cardiogenic shock: a multicentre analysis of clinical profiles, management and outcomes. Int J Cardiol. 2023, 383:82-8. 10.1016\/j.ijcard.2023.05.004","journal-title":"Int J Cardiol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ando.2020.03.011","article-title":"Acute stress cardiomyopathy: heart of pheochromocytoma","volume":"82","author":"Cornu E","year":"2021","unstructured":"Cornu E, Motiejunaite J, Belmihoub I, Vidal-Petiot E, Mirabel M, Amar L. Acute stress cardiomyopathy: heart of pheochromocytoma. Ann Endocrinol (Paris). 2021, 82:201-5. 10.1016\/j.ando.2020.03.011","journal-title":"Ann Endocrinol (Paris)"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1378\/chest.118.4.1221","article-title":"Pheochromocytoma crisis, cardiomyopathy, and hemodynamic collapse","volume":"118","author":"Kizer JR","year":"2000","unstructured":"Kizer JR, Koniaris LS, Edelman JD, St John Sutton MG. Pheochromocytoma crisis, cardiomyopathy, and hemodynamic collapse. Chest. 2000, 118:1221-3. 10.1378\/chest.118.4.1221","journal-title":"Chest"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1530\/EDM-17-0122","article-title":"Management of an acute catecholamine-induced cardiomyopathy and circulatory collapse: a multidisciplinary approach","volume":"2017","author":"Casey RT","year":"2017","unstructured":"Casey RT, Challis BG, Pitfield D, et al.. Management of an acute catecholamine-induced cardiomyopathy and circulatory collapse: a multidisciplinary approach. Endocrinol Diabetes Metab Case Rep. 2017, 2017:17-0122. 10.1530\/EDM-17-0122","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1177\/0267659120908413","article-title":"Extracorporeal life support for phaeochromocytoma-induced cardiogenic shock: a systematic review","volume":"35","author":"Matteucci M","year":"2020","unstructured":"Matteucci M, Kowalewski M, Fina D, et al.. Extracorporeal life support for phaeochromocytoma-induced cardiogenic shock: a systematic review. Perfusion. 2020, 35:20-8. 10.1177\/0267659120908413","journal-title":"Perfusion"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2012-303028","article-title":"Neurological manifestations of phaeochromocytomas and secretory paragangliomas: a reappraisal","volume":"84","author":"Anderson NE","year":"2013","unstructured":"Anderson NE, Chung K, Willoughby E, Croxson MS. Neurological manifestations of phaeochromocytomas and secretory paragangliomas: a reappraisal. J Neurol Neurosurg Psychiatry. 2013, 84:452-7. 10.1136\/jnnp-2012-303028","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1055\/s-0042-106725","article-title":"Attention deficit hyperactivity disorder in pediatric patients with pheochromocytoma and paraganglioma","volume":"48","author":"Batsis M","year":"2016","unstructured":"Batsis M, Dagalakis U, Stratakis CA, et al.. Attention deficit hyperactivity disorder in pediatric patients with pheochromocytoma and paraganglioma. Horm Metab Res. 2016, 48:509-13. 10.1055\/s-0042-106725","journal-title":"Horm Metab Res"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1097\/WNF.0000000000000380","article-title":"A severe adverse effect of atomoxetine: hypertensive crisis","volume":"43","author":"Guldiken G","year":"2020","unstructured":"Guldiken G, Karayagmurlu A. A severe adverse effect of atomoxetine: hypertensive crisis. Clin Neuropharmacol. 2020, 43:50-1. 10.1097\/WNF.0000000000000380","journal-title":"Clin Neuropharmacol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/288060-atomoxetine-induced-pheochromocytoma-and-paraganglioma-crisis-managed-with-veno-arterial-extracorporeal-membrane-oxygenation","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T11:23:58Z","timestamp":1731497038000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/288060-atomoxetine-induced-pheochromocytoma-and-paraganglioma-crisis-managed-with-veno-arterial-extracorporeal-membrane-oxygenation"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,13]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.73582","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11,13]]}}}